We need around 140 donations in the next four days to succeed with
our September fundraising challenge! We're striving for 818 unique
contributions before September 30th, which would make this the most
contributions we've ever received in a single month.
It's a challenge to do fundraising for Erowid Center. Many people ask
why we need money at all. Some feel that obtaining donations should
be easy for us, given the number of visitors who use the site. Still
others believe that we receive funding from the government.
Erowid is a small non-profit that depends entirely on donations from
people like you
in order to continue to document psychoactive
drugs. We have a relatively modest budget, but we do need to pay our
staff (the equivalent of 3.5 full-time people) who work hard every
day to keep the site up-to-date, check facts, track emerging drugs
and drug trends, and keep the servers up, running, and secure.
Please support Erowid with a contribution of any size in September!
The death of 18-year-old American Kyle Nolan is drawing attention
after he traveled to the Madre de Dios region of Peru to attend an
ayahuasca retreat and died under unknown conditions. Shockingly, the
shaman in charge of the retreat buried his body and lied to family
members for more than two weeks before leading police to the body.
Nolan's father held a fundraiser to cover costs to bring the body
home for further autopsy while toxicology results are pending in Peru.
Rencontres Nationales de la Réduction des Risques Liés à l'Usage de Drogues
(Oct 25-26, 2012) in Paris, France
Plenaries, panels, posters, and exhibitions on harm reduction
projects and policies in francophone Europe (esp. France). Hosted
by l'Association Franç¨aise pour la Rˇéduction des risques [AFR;
French Association for Risk Reduction].
Over the last four years, Erowid volunteers have worked countless
hours transcribing and proofreading lab books produced from the 1960s
through the 1980s by chemist Alexander Shulgin. The first fully
digital and searchable version available for public comment is Book 6.
Inspired by transformative experiences with 5-MeO-DMT, author James
Oroc examines the paradox inherent in embracing entheogens --
psychoactive substances used to bring about a spiritual experience --
while remaining uncomfortable with the concept of "God" or divinity.
Issue 7 of the Psychozoic Press (Spring 1984) features Part 3
of an interview with Terence McKenna, Tom Lyttle's personal account
"LSD vs Insanity", details of ayahuasca drinkers amongst the Chama
Indians, a 2C-B trip report, book reviews, reader letters, and more.
An interview with Albert Hofmann in 1983, by Don Rothenberg, PhD.
Transcoded from VHS with some quality issues, this is nonetheless an
interesting and previously unpublished interview with the inventor of
LSD from 29 years ago.
In June, Erowid crew members Jon Hanna and Tania Manning interviewed
Dr. David Nichols just before he retired
from his position as Chair
in Pharmacology at Purdue University College of Pharmacy's Department
of Medicinal Chemistry and Molecular Pharmacology. Highlights of this
interview will appear in the November issue of Erowid Extracts
of the topics discussed was Nichols' work with LSD analogs:
"LSD sorta violates the principles of medicinal chemistry. You expect
to see potency change in a regular way. When you see it change very
abruptly, that's when there must be some sensitive spot, or there's
a steric restriction, or something. So we did a lot of amide
modification, and made a lot of derivative analogs of LSD. We still
don't know why LSD is as potent as it is. But it interacts with a lot
of different receptors."
The Erowid crew wishes Dr. Dave the best with his new position at the
University of North Carolina at Chapel Hill.
The few published accounts of deaths linked to the recreational use
of this psychedelic phenethylamine fall into the categories of
pharmacological fatalities and behavioral fatalities.
TEDI's report about the results of on-site drug analysis conducted
by TEDI and Energy Control at the large Boom Festival in Portugal
in july/August 2012. The most common drugs found were MDMA, LSD,
cocaine, ketamine, and a substance Energy Control has not yet identified.
Commentary and effects description for methylisopropyl-lysergamide
(lamid), an LSD analog that appeared on the LSD market in the 1990s.
A short bit about the use of antihistamines to reduce the side
effects (itching, nausea, vertigo) of opiates and opioids.
EcstasyData is a project of Erowid Center that conducts laboratory
testing of street ecstasy tablets and publishes these and other test
Contains Caffeine, Nicotine, and Naphthalene.
Contains Caffeine, BZP, MDMA, and Methamphetamine.
Contains TFMPP, Caffeine, BZP, MDMA, and Methamphetamine.
If you find Erowid a useful resource and are interested in supporting
its future development, please consider donating or becoming a member.
Donations to Erowid Center are tax-deductible in the United States.
- To UNSUBSCRIBE - send an empty email to: firstname.lastname@example.org
- To SUBSCRIBE - send an empty email to: email@example.com